Related Experiment Video
Updated: Jun 19, 2026

A Retrograde Implantation Approach for Peritoneal Dialysis Catheter Placement in Mice
Published on: July 20, 2022
Cardiovascular disease in peritoneal dialysis patients
R G Fassett1, R Driver, H Healy
1Renal Research, Royal Brisbane and Women's Hospital, Brisbane, Queensland, Australia. r.fassett@uq.edu.au
Insights
Patients undergoing peritoneal dialysis face high cardiovascular risks due to atherosclerosis, influenced by traditional and non-traditional factors. Further research is needed to clarify long-term cardiovascular outcomes comparing dialysis types.
Area of Science:
- Nephrology
- Cardiology
- Vascular Biology
Background:
- Peritoneal dialysis patients exhibit high cardiovascular morbidity and mortality, linked to atherosclerotic cardiovascular disease.
- Risk factors include traditional (hypertension, diabetes) and non-traditional (oxidative stress, inflammation) elements.
- Endothelial dysfunction and arterial stiffness precede atherosclerosis, with measures like pulse wave velocity predicting outcomes.
Purpose of the Study:
- To investigate the association between oxidative stress, inflammation, and vascular/myocardial structure and function in peritoneal dialysis patients.
- To compare cardiovascular outcomes and risks between peritoneal dialysis and hemodialysis.
- To evaluate the long-term cardiovascular impact of different renal replacement therapies.
Main Methods:
- Review of existing randomized controlled trials and observational studies.
- Analysis of registry data comparing mortality rates between peritoneal dialysis and hemodialysis.
- Assessment of oxidative stress, inflammation, and arterial stiffness markers.
Main Results:
- Peritoneal dialysis is linked to lower oxidative stress and inflammation compared to hemodialysis.
- Conflicting results exist regarding the long-term cardiovascular advantage of peritoneal dialysis versus hemodialysis.
- Some data suggest lower initial mortality with peritoneal dialysis, but higher long-term mortality, while other data contradict this.
Conclusions:
- The choice between peritoneal dialysis and hemodialysis involves complex cardiovascular considerations.
- Evidence on the differential long-term cardiovascular effects of these therapies remains conflicting.
- Further long-term studies are essential to definitively assess cardiovascular outcomes in peritoneal dialysis patients.
Abstract:
Patients on peritoneal dialysis have a high level of morbidity and mortality associated with atherosclerotic cardiovascular disease and they also have an increased risk of sudden death. The atherosclerosis seen in peritoneal dialysis patients is associated with both traditional cardiovascular risk factors such as low levels of physical activity, hyperlipidemia, hypertension, diabetes and smoking as well as non-traditional risk factors such as elevated oxidative stress and inflammation. The atherosclerosis may be preceded by endothelial dysfunction and increased arterial stiffness. Measures of arterial stiffness such as aortic pulse wave velocity predict morbidity and mortality. Numerous studies have reported that the elevated levels of oxidative stress and inflammation in this population are associated with arterial stiffness and in turn with the development of cardiovascular disease. A number of studies have reported that peritoneal dialysis is associated with lower levels of oxidative stress and inflammation compared to haemodialysis. A small number of trials have extended this work to determine associations between oxidative stress and inflammation with vascular or myocardial structure and function with equivocal results. The decision to undergo either peritoneal or haemodialysis is based on many factors which include the differential damage the renal replacement therapy may have on the cardiovascular system. Current evidence suggests this may vary over time. Previous randomised controlled trials and many other observational studies have produced conflicting results as to which therapy may have a cardiovascular advantage. Some registry data suggests peritoneal dialysis is associated with a lower mortality than haemodialysis in the first one-two years but thereafter may be higher on peritoneal dialysis than haemodialysis. Other registry data do not support this. Further long-term studies assessing surrogate and hard endpoint cardiovascular outcomes in peritoneal dialysis are required.
Related Concept Videos
Peritoneal Dialysis II: Peritoneal Dialysis Systems and Complications
Peritoneal Dialysis III: Nursing Management
Hemodialysis II: Procedure and Complications
Peritoneal Dialysis I: Introduction and Procedure
Dialysis
Acute kidney injury develops suddenly and can be caused by pre-renal causes (e.g., hypovolemia, shock), intrinsic renal causes (e.g., acute tubular necrosis), or post-renal causes (e.g., urinary obstruction). In contrast, chronic renal failure progresses gradually over time and is often...
Dialysis
